LabMedUK Awards

QUALIFYING CRITERIA

Any professional, either in training or in work, can submit an abstract to be considered for a poster or a clinical case presentation.

Each applicant (who must be the first author, if submitting on behalf of a group) must certify that the work, or a substantial and clearly defined part of it, is their own work.

Applicants should consider how their work contributes to EDI and sustainability values.

HOW TO SUBMIT

Applicants must use the Abstract submission form to apply. Prior to accessing the form, users will be required to create an account with the Oxford Abstracts platform.

During the abstract submission process, authors can indicate whether they would like their submission to be considered for one of the Poster Prizes (Audit and Clinical Case), for a Clinical Cases Oral Presentation, or for the Medal Award.

Please click on the Medal Award section on the LabMedUK Awards page for more information about this award.

The abstract should be completed in no more than 300 words.

Before submitting, you can check our Poster abstract writing guidelines, our Poster guidelines and our Clinical case presentation guidelines.

The deadline for submitting your poster abstract has been extended to: 9:00 am, 20 February (GMT) each year. 

HOW IT WILL BE SCORED AND ACCEPTED

All abstract submissions are anonymised before being reviewed.

Audit submissions are reviewed by the Audit committee. Clinical Case submissions are reviewed by the clinical science review committee, as well as by the Clinical Case Oral Presentation session chair.

For Clinical Cases, criteria for selection include a clear description of the clinical presentation, presentation of the test results, appropriate interpretation of those results.

For Clinical Audit, a successful submission includes a clear description of the area of practice, the standards/ guidelines used, changes introduced, and re-audit.

Preference will be given to cases with multi-disciplinary involvement, rare case studies, or an unusual presentation of a more common case.

The authors of the highest scoring Clinical Cases will be contacted to discuss their preference for either oral or poster presentation. Note that case abstracts presented orally at the meeting session will not be displayed as posters

Submissions for the Medal Award will be reviewed and shortlisted by an Award Committee comprising the Association’s President, Past President or President Elect, Director of Publications and Communications, Director of Education, Training and Workforce and the Director of Conferences and Events.

During the conference a judging panel will be convened for the shortlisted Audit and Clinical Case posters. This judging panel usually comprises the Chair of the Clinical Science Review Committee, the Chair of the National Audit Committee and the Director of Scientific Affairs, who will discuss posters with the authors. Authors will be expected to attend their poster during the lunch break at a time organised by the judging panel.

The Clinical Cases Oral Presentation Session is voted for by the audience.

The Medal Award oral presentations and question and answer session will be scored by the judging panel as outlined above.

The winners will be announced and presented with their prizes at the closing ceremony of the conference.

POSTER PRIZES

The winner of the Medal Award receives £300 and the runner up £150.

The winner for each other category receives £100 and the runner-up receives £50.

Authors should not submit their abstract into more than one category. Clinical Cases should not be submitted for the Medal Award. 

Should authors have more than one abstract selected for oral presentation in one category, they will be asked to select their preferred abstract for presentation.

FURTHER QUESTIONS

If you have any questions about the Poster Abstracts or the submission process, please don’t hesitate to contact the Team at [email protected]. 

THE MEDAL AWARD 

Awarded annually based on an oral communication presented by a member in active training at LabMedUK. The winner receives a £300 cash prize, while the runner-up receives £150. 

QUALIFYING CRITERIA 

Applicants must be Members of the Association who were in active training (i.e. working towards, but not yet having acquired FRCPath) when the work submitted for the award was completed. Applicants may submit this work as an abstract to the meeting within one year of being awarded FRCPath. 

Applicants must certify that the work, or a substantial and clearly defined part of it, is their own work.

Cases will not be accepted for the Medal Award.   

Applicants should outline the impact that their project has had and should also consider sustainability and EDI within their project.

HOW TO SUBMIT 

The shortlist for the Medal Award will be selected from the Poster Abstract submissions. 

In the Abstracts submissions form, applicants should submit an abstract of no more than 300 words. Please read the guidance on how to submit your abstract in the Poster Prizes section of the LabMedUK Awards page. 

Applicants must indicate on the submission form that the author wishes their abstract, if accepted, to be considered for the Medal Award. 

The deadline for submitting your poster abstract, including consideration for the Medal Award, is 9:00 am, 20 February each year (GMT).

HOW IT WILL BE SCORED AND AWARDED 

The judges on the Award Committee will look for evidence of original science that is relevant to Laboratory Medicine, that is completed by the presenter and has impact on the patient pathway.  

Shortlisting and judging is completed by an Award Committee, comprising the Association’s President, Past President or President Elect, Director of Publications & Communications, Director of Education, Training & Workforce, and the Director of Conferences and Events.  

Shortlisted Medal Award applicants will be informed not less than 6 weeks before the Award. At LabMedUK there will be a separate session dedicated to the Award presentations. Participants will be given 15 minutes to make their presentation with a further 5 minutes for questions. Judges will also look for a clear and interesting delivery, careful timing, good audio-visual aids, and the ability to discuss the project and answer questions and evidence of the applicant’s contribution to the project.  

The winner and runner-up will be announced at the LabMedUK closing ceremony. 

 

DESCRIPTION 

The Impact Award is an opportunity for Members of the Association working in Laboratory Medicine to showcase and be recognised for an initiative they have delivered, either as an individual or group, which has resulted in positive change to a service. 

This can be positive change in relation to: 

• The patient pathway 
• Health systems and services 
• The laboratory workforce  
• Environmental sustainability 
• Inclusive healthcare 

QUALIFYING CRITERIA 

The overarching qualifying criteria is that the initiative submitted is innovative to the sector and/or your workplace, and that it resulted in demonstrable change that benefitted the stakeholders involved. 

This initiative must have been implemented, and not be solely research or a study. However, it may be something that was already implemented in other industries, communities or countries, that you adapted and refined to solve a challenge related to your clinical practice and/or stakeholders involved in that practice. The initiative must have been delivered within the previous 5 years of the submission cut-off date. 

The person(s) awarded must be able to deliver a plenary lecture about the initiative at LabMedUK. In the case of a group submission, the awardees can nominate a lead presenter or present as a group. 

HOW TO SUBMIT 

Submission is by self-nomination and completion of the Impact Award online submission form by the corresponding presenter. The form requires the applicant to fill in the following sections, in no more than 1000 characters per section: 

1. The background to the initiative 

2. The action taken through the initiative 

3. The impact the initiative had 

The deadline for submitting applications to the Impact Award is 09:00 am, 28 February each year (GMT). 

HOW IT WILL BE SCORED AND AWARDED 

Anonymised applications are scored by the Executive committee based on the ability to evidence the positive change that resulted from the implementation of the initiative. 

A successful submission will clearly demonstrate the problem you were facing (baseline), the steps you took to address it (implementation), and how those made a difference (impact). 

Things that will be considered when scoring your submission and that you should highlight in it are: 

• What KPIs (if any) did you use to measure the level of success of your initiative? 
• What qualitative evidence can you provide demonstrating the success of your initiative? 
• How big was the problem you were trying to solve? 
• How unique is your initiative? 
• How easy was it to implement? 
• How many people and/or practices benefitted from this initiative? 
• Can it be scaled for the benefit of others? 

PRIZE 

The Awardee(s) will present their work at LabMedUK and will receive a suitable memento. 

FURTHER QUESTIONS 

If you have any questions about the Impact Award or its submission process, please don’t hesitate to contact the Team at [email protected]. 

DESCRIPTION

The award is to recognise an outstanding contribution to Laboratory Medicine by an Association Member, who is normally resident in the UK or Republic of Ireland.

QUALIFYING CRITERIA

The recipient will be a Member of the Association, normally resident in the United Kingdom or Republic of Ireland, who is acknowledged as having made an outstanding contribution to Laboratory Medicine and has been nominated by their peers.

SUBMISSION REQUIREMENTS

Written nominations are sought from a proposer, who is a Member of the Association.  Nominations must be accompanied by a supporting statement outlining the nature of the contribution made by the nominee and the reasons for consideration for the Award. Nominations can be made through the online nomination form, which can be found here, and should include a supporting statement of up to 10,000 characters outlining the nature of the contribution made by the nominee and the reasons for consideration for the Award in line with the scoring criteria outlined below.

Members can also self-nominate for the Laboratory Medicine Foundation Award.

All Laboratory Medicine Foundation Award nominations must be submitted by 9:00 am, 31 January each year (GMT).

 

PROCESS OF AWARDING

• The recipient is selected by the Association’s Nominations Committee and the successful nominee will be advised 2-3 months prior to the award being made.
• The submission will be scored out of 10 marks*, the following criteria will be considered during the scoring process:
  • Significant leader in innovation or service delivery
  • Significant achievements in teaching or training
  • Has led/Chaired/been a member of a national programme in their specialist field
  • Has led/Chaired/been a member of an international working group/subcommittee in specialist field
  • Published Manuscript in scientific journal with international peer reviewing
  • Scientific projects – PhD/postdoc research and scientific societies’ working group positions

*The score should be an overall score for excellence in one or more of these areas, the individual does not have to display excellence in all of the above. i.e a nominee who scores well, but not outstanding, in all of the above should not outscore an individual who scores outstandingly in one or two criteria.

• Should more that one nomination be received for an individual, each submission will be scored separately on its own merit.
• Council is informed of this outcome at its first meeting after the selection is completed. The awardee is invited to accept the award by letter from the President. The Award is presented by a representative of the Association’s Executive after the recipient has delivered the Laboratory Medicine Foundation Lecture. Recipients must be available to present the lecture at the LabMedUK meeting that follows their nomination.

PRIZE

The Laboratory Medicine Foundation Award is presented annually at LabMedUK. The recipient will give a plenary lecture (The Laboratory Medicine Foundation Award Lecture) on the area of laboratory medicine for which they were nominated. A suitable memento will also be given to the recipient.

This prestigious award was introduced in 2011, replacing the Siemens Award Lecture and the Roche Diagnostics Award Lecture (previous winners of these awards can also be found below).

• Nominated persons should normally be practising clinical biochemists from outside of the UK who have made a major contribution to clinical biochemistry – in practice, research or in education.

• The recipient is invited to give a state-of-the-art lecture in their area of expertise and the Award will be a certificate and an honorarium.

• In the first year of the Award, the recipient was nominated by the Annual National Meeting Scientific Programme Committee. Thereafter (2012 onwards), written nominations have been sought through the LabMed News 18 months prior to the Award being made. This will comprise a supporting proposer and 2 seconders who are members of the Association, but not Members of Council or officers of standing committees.

• If there are no nominations, the LabMedUK Scientific Programme Committee will be invited to nominate a recipient.

• The nominee must be willing to be proposed and willing to deliver an Award Lecture at LabMedUK.

• The nomination is ratified by Executive. If there is more than 1 nomination, the recipient will be selected by Executive.

• Council is informed of the outcome at its first meeting after selection of the recipient.

 

The Association for Diagnostics & Laboratory Medicine (ADLM) Transatlantic Lecture was inaugurated in 1998 when the National Meeting was held in Glasgow. This was the 50th Anniversary of the founding of the ADLM (previously the AACC). The procedure for selecting the Transatlantic Lecture has evolved over this time.

The speaker’s expenses will cover travel (economy) plus registration and accommodation for the full meeting.

• The proposed speaker is selected by the Scientific Programme Organising Committee and Association's Executive for the National Meeting at which the lecture will be presented. The ADLM is then consulted through its President about the person selected.
• The major qualification for the speaker is that he or she is a distinguished, leading clinical scientist from the American Continent. The person will be able to deliver a plenary lecture on a subject usually relevant to one of the themes of the conference.

• The person will be able to deliver a plenary lecture on a subject usually relevant to one of the themes of the conference.

• The lecturer does not need to be a Member of ADLM nor only be resident in the USA.